Envisagenics
From RNA insight to smarter discovery
Envisagenics utilises its SpliceCore AI platform to discover novel therapeutic targets within RNA splicing. The company focuses on oncology and neurodegeneration by combining deep biological expertise with advanced artificial intelligence.
| Best for | biopharmaceutical researchers in oncology and neurodegeneration |
| Website | envisagenics.com |
Strengths and trade-offs
- The AI tool discovers drug targets missed by traditional methods through RNA splicing analysis.
- Envisagenics offers collaborative partnerships to turn scientific innovation into life-changing therapies.
Appears in
Alternatives to Envisagenics
 Relay TherapeuticsPioneering motion-based drug design through protein dynamics | #1 in Best AI drug discovery platforms | 80.0 |
 SchrödingerOpening new worlds for molecular discovery | #2 in Best AI drug discovery platforms | 80.0 |
 Valo HealthThis is drug discovery re-imagined | #3 in Best AI drug discovery platforms | 80.0 |
 IktosPioneering AI and robotics in drug discovery | #4 in Best AI drug discovery platforms | 78.0 |
 Insilico MedicineGenerative AI software for drug discovery | #5 in Best AI drug discovery platforms | 78.0 |
 TurbineA lab without limits for biopharma discovery | #6 in Best AI drug discovery platforms | 78.0 |
Questions about Envisagenics
Who is Envisagenics best for?
Envisagenics is best for biopharmaceutical researchers in oncology and neurodegeneration.
Where does Envisagenics rank?
Envisagenics is ranked #8 in Best AI drug discovery platforms (Lister Score 76.0).
What are the best alternatives to Envisagenics?
The closest alternatives on Lister are Relay Therapeutics (#1 in Best AI drug discovery platforms), Schrödinger (#2 in Best AI drug discovery platforms) and Valo Health (#3 in Best AI drug discovery platforms).
Is this your company?
Claim Envisagenics to suggest corrections to its listing (pricing, features, details) or ask about an enhanced profile. We review every claim before anything changes.